Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FAST-bact

Financiado

Cerrado

A novel fast test for antibiotic susceptibility testing for Gram positive and Gr...

A novel fast test for antibiotic susceptibility testing for Gram positive and Gram negative bacteria In this project, the consortium will develop FAST-bact kits, a breakthrough test method to rapidly determine antibiotic drug susceptibility (AST), which will improve treatment of patients with serious bacterial infections. The cur... ver más

31/05/2021

FASTinov

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

FASTINOV SA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-05-31

FTIPilot-01-2016: Fast Track to Innovation Pilot

I+D

Cerrada hace 8 años

0% 72% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

FASTinov

1.32M€ | Lider

ITF RESEARCH PHARMA

574.31K€ | Participante

Clonit

240.53K€ | Participante

SERMAS

276.25K€ | Participante

Proyectos interesantes

RAPID

Medical Technol...

Data Science

150K€ Cerrado

TEMPOTEST-QC

Medical Technol...

Data Science

4M€ Cerrado

BADGER

Medical Technol...

Data Science

71K€ Cerrado

BacterOMIC

Medical Technol...

Data Science

3M€ Cerrado

TAILORED-TREATMENT

Medical Technol...

Data Science

8M€ Cerrado

ROUTINE

Medical Technol...

Data Science

4M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 53 meses Fecha Inicio: 2016-12-16
Fecha Fin: 2021-05-31

Líder del proyecto

FASTINOV SA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In this project, the consortium will develop FAST-bact kits, a breakthrough test method to rapidly determine antibiotic drug susceptibility (AST), which will improve treatment of patients with serious bacterial infections. The current methodology in AST has a turnaround time of at least 24 hours, and up to 48 hours in case of blood cultures, whereas this novel flow cytometry-based test delivers results within 1-2 h. This will enable clinicians to start optimal antibiotic treatment as soon as possible, with a major impact on health and quality of life of patients and on health care costs. Resistance to antibiotic treatment leads to difficulties in the treatment of patients with bacterial infections. The FAST-bact project will have great impact on treatment of patients with (resistant) bacterial infections; a susceptibility report in useful time will reduce the use of broad spectrum or last line antibiotics. The FAST-bact tests will be marketed to clinical and microbiology diagnostic laboratories, in order to perform fast and accurate AST testing and optimize treatment for these patients. The tests will be marketed as a microplate-based kit, containing panels of antibiotics and compatible probes to determine the effect of the antibiotics, and including a software package for interpretation of results. The consortium will perform clinical validation of the tests against European and US standard methods. The previously designed decision support software, which allows fast and convenient result delivery, will be finalised and implemented. The technical file for regulatory proceedings will be drafted and large-scale production will be started. A commercialisation and dissemination plan will be drafted for market launch of the FAST-bact tests, first in Europe with expansion to other regions. In addition to these first products, opportunities will be explored to utilize the FAST-bact method for other tests, which will be included in the exploitation plan.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores